Thermo Fisher Scientific (TMO -0.08%), a leading provider of scientific instrumentation, reagents and consumables, and specialty diagnostics, reported its second quarter results for fiscal 2025 on July 23, 2025. The company delivered higher revenue and non-GAAP earnings per share than Wall Street estimates, with revenue (GAAP) was $10.85 billion versus the$10.68 billion analyst consensus, and Adjusted EPS was $5.36 against a$5.23 estimate. While overall revenue (GAAP) grew and product launches remained st ...